Bogart Wealth’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$143 Hold
4
– – ﹤0.01% 1959
2026
Q2
$110 Sell
4
-142
-97% -$3.77K ﹤0.01% 1932
2026
Q1
$3.92K Hold
146
– – ﹤0.01% 1127
2025
Q4
$4.5K Hold
146
– – ﹤0.01% 1023
2025
Q3
$4.48K Hold
146
– – ﹤0.01% 999
2025
Q2
$3.02K Hold
146
– – ﹤0.01% 1036
2025
Q1
$2.86K Hold
146
– – ﹤0.01% 1014
2024
Q4
$3.05K Hold
146
– – ﹤0.01% 1011
2024
Q3
$3.56K Buy
+146
New +$3.9K ﹤0.01% 890
2024
Q1
– Sell
-50
Closed -$1.59K – 1092
2023
Q4
$1.59K Hold
50
– – ﹤0.01% 918
2023
Q3
$1.76K Buy
+50
New +$1.9K ﹤0.01% 897

Other funds holding GMAB

Bogart Wealth's GMAB Position: Q3 2026 in Review

Bogart Wealth held its Genmab (GMAB) position steady in Q3 2026 at 4 shares worth $143. The position accounts for ﹤0.01% of the portfolio, ranked #1959.

Bogart Wealth first reported a position in GMAB in Q3 2023 and has held it in 11 quarters since. The position peaked at $4.5K in Q4 2025. 333 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.

  • Bogart Wealth held 4 shares of Genmab worth $143 as of Q3 2026.
  • Bogart Wealth left its Genmab share count unchanged in Q3 2026.
  • Genmab made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #1959 holding.
  • Bogart Wealth first reported a position in Genmab in Q3 2023 and has held it in 11 quarters since.
  • Bogart Wealth's Genmab position peaked at $4.5K in Q4 2025.
  • 333 funds tracked by Wall St. Rank held Genmab as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.